Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 85
  1. Dec 15, 2025 · 17:09 · RVV

    Revive Therapeutics primes the pump on Bucillamine

    Revive Therapeutics primes the pump on Bucillamine

    01
  2. Dec 15, 2025 · 17:05 · PTEC

    PRINCIPAL TECHNOLOGIES CLOSES PRIVATE PLACEMENT FINANCING

    PRINCIPAL TECHNOLOGIES CLOSES PRIVATE PLACEMENT FINANCING

    02
  3. Dec 15, 2025 · 17:01 · VIVI

    TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent

    TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent

    03
  4. Dec 15, 2025 · 16:30 · RX

    BioSyent Announces Renewal of Normal Course Issuer Bid

    BioSyent Announces Renewal of Normal Course Issuer Bid

    04
  5. Dec 15, 2025 · 12:29 · MDX

    MedX Health reviews 2025

    MedX Health reviews 2025

    05
  6. Dec 15, 2025 · 08:30 · AIAI

    NetraMark Achieves Major FDA Milestone

    NetraMark Achieves Major FDA Milestone

    06
  7. Dec 15, 2025 · 07:30 · RVV

    Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

    Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

    07
  8. Dec 15, 2025 · 07:30 · QIPT

    Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    08
  9. Dec 15, 2025 · 07:30 · QIPT

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    09
  10. Dec 15, 2025 · 06:00 · MDX

    MedX Health 2025 YEAR REVIEW

    MedX Health 2025 YEAR REVIEW

    10
  11. Dec 12, 2025 · 17:45 · TLT

    Theralase cancels $4.5M placement, arranges placement

    Theralase cancels $4.5M placement, arranges placement

    11
  12. Dec 12, 2025 · 17:40 · MYTC

    MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

    MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

    12
  13. Dec 12, 2025 · 17:25 · BLCO

    Bausch + Lomb allocates $2.8B to refinance term loans

    Bausch + Lomb allocates $2.8B to refinance term loans

    13
  14. Dec 12, 2025 · 17:02 · NRX

    Nurexone prepares small-scale manufacturing for ExoPTEN

    Nurexone prepares small-scale manufacturing for ExoPTEN

    14
← Newer Older →